Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs)
$58.80
pos +0.00
+0.00%
Today's Range: 58.66 - 59.50 | BMY Avg Daily Volume: 6,503,700
Last Update: 11/21/14 - 4:05 PM EST
Volume: 0
YTD Performance: 10.63%
Open: $0.00
Previous Close: $58.61
52 Week Range: $46.30 - $59.50
Oustanding Shares: 1,658,776,491
Market Cap: 97,220,890,138
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 9 8 8
Moderate Buy 0 1 1 1
Hold 8 7 8 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.18 2.03 2.14 2.09
Latest Dividend: 0.36
Latest Dividend Yield: 2.46%
Dividend Ex-Date: 10/01/14
Price Earnings Ratio: 36.18
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
36.18 36.00 25.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
17.62% 12.32% 93.29%
GROWTH 12 Mo 3 Yr CAGR
Revenue -7.00 -0.16 -0.06
Net Income 3.20 -0.43 -0.17
EPS 32.90 -0.13 -0.05
Earnings for BMY:
EBITDA 3.86B
Revenue 16.39B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.40 $0.57 $1.79 $1.78
Number of Analysts 9 2 11 12
High Estimate $0.42 $0.64 $1.81 $2.19
Low Estimate $0.37 $0.50 $1.76 $1.52
Prior Year $0.51 $0.46 $1.82 $1.79
Growth Rate (Year over Year) -21.35% 23.91% -1.55% -0.61%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Nov 13, 2014 | 7:28 AM EST
BMY downgraded to Equal-weight from Overweight, said Morgan Stanley. Stock is now discounting higher odds of success for new drug in de...
Remember these franchises and who captains them.
Americans are living much longer these days -- and there are a number of ways to invest.

This Morning's Market Setup Real Money Pro($)

Where it began.
Bullish
Oct 16, 2014 | 8:13 AM EDT
BMY was upgraded to Outperform from Market Perform, BMO Capital said. $55 price target. Consensus expectations are low and have increas...
Stop picking on PepsiCo, Allergan and Apple.
Bearish
Oct 08, 2014 | 8:16 AM EDT
BMY sell rating reiterated, said MKM. The company announced it will not seek FDA approval for two major drugs, and has withdrawn an add...
In the end, the market will find its feet. 

Finding a Place to Hide Real Money Pro($)

My strategy for when markets get choppy.
Update
Aug 27, 2014 | 7:15 AM EDT
BMY was initiated with a Hold rating, Deutsche Bank said. Valuation call, based on a $52 price target. 

Columnist Conversations

Well this is confusing...our models were calling for a run to 2072 before a bearish reversal would be possible...
Revenue Trend Apple is one of the most remarkable companies in the world, not just because it has the largest...
HOG has topped out. The stock's twelve day winning streak is ending today with and ugly reversal. HOG o...
Seems like there was a bid underneath at the crucial 2:45 p.m. hour.. day saver? still not sure..

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.